Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsNeoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasmActive, not recruitingPhase 22026-08-03NCT03878095

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Huntsman Cancer Institute/University of UtahSalt Lake CityUnited States249
Johns Hopkins University/Sidney Kimmel Cancer CenterBaltimoreUnited States238
Northwestern UniversityChicagoUnited States727
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
Smilow Cancer Center/Yale-New Haven HospitalNew HavenUnited States91
Smilow Cancer Hospital Care Center-TrumbullTrumbullUnited States133
UF Health Cancer Institute - GainesvilleGainesvilleUnited States153
University of Alabama at Birmingham Cancer CenterBirminghamUnited States186
University of Wisconsin Carbone Cancer Center - University HospitalMadisonUnited States249
UT MD Anderson Cancer CenterHoustonUnited States204
Wayne State University/Karmanos Cancer InstituteDetroitUnited States196
Weisberg Cancer Treatment CenterFarmington HillsUnited States135
Yale UniversityNew HavenUnited States352